OX40: a win–win path to tumor immunity
Year: 2008
Type: article
Abstract: ![Graphic][1]
Mice injected with agonist anti-OX40 antibody remain tumor-free after injection with cancer cells. Regulatory T (T reg) cells prevent autoimmunity by keeping self-reactive effector T cells in check, but this suppression becomes counterproductive when the effector cells
DOI: 10.1084/jem.2054iti2
Author: Caitlin Sedwick
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2092411683
